Healthcare provider profile · identity verified

Jerry Fred Duris, M.D.

Family Practice · PUYALLUP, WA · NPI 1760540215

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	628	193
Losartan Potassium	Losartan Potassium	308	93
Amlodipine Besylate	Amlodipine Besylate	286	82
Levothyroxine Sodium	Levothyroxine Sodium	279	72
Metoprolol Succinate	Metoprolol Succinate	261	82
Lisinopril	Lisinopril	205	61
Metformin Hcl	Metformin Hcl	140	46
Omeprazole	Omeprazole	140	39
Tamsulosin Hcl	Tamsulosin Hcl	119	36
Gabapentin	Gabapentin	115	35
Eliquis	Apixaban	111	26
Hydrochlorothiazide	Hydrochlorothiazide	106	34
Alendronate Sodium	Alendronate Sodium	99	31
Ozempic	Semaglutide	99	20
Sertraline Hcl	Sertraline Hcl	93	26
Potassium Chloride	Potassium Chloride	91	28
Rosuvastatin Calcium	Rosuvastatin Calcium	88	27
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	85	17
Paroxetine Hcl	Paroxetine Hcl	81	22
Quetiapine Fumarate	Quetiapine Fumarate	76	21
Prednisone	Prednisone	74	37
Furosemide	Furosemide	69	20
Pantoprazole Sodium	Pantoprazole Sodium	66	23
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	63	suppressed
Montelukast Sodium	Montelukast Sodium	62	16
Carvedilol	Carvedilol	61	19
Duloxetine Hcl	Duloxetine Hcl	59	13
Allopurinol	Allopurinol	54	18
Ipratropium Bromide	Ipratropium Bromide	51	17
Oxybutynin Chloride	Oxybutynin Chloride	44	15
Ropinirole Hcl	Ropinirole Hcl	43	suppressed
Finasteride	Finasteride	42	13
Jardiance	Empagliflozin	41	13
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	39	31
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	39	13
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	37	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	35	suppressed
Irbesartan	Irbesartan	35	17
Metoprolol Tartrate	Metoprolol Tartrate	35	12
Albuterol Sulfate Hfa	Albuterol Sulfate	33	19
Warfarin Sodium	Warfarin Sodium	33	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	32	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	32	suppressed
Pravastatin Sodium	Pravastatin Sodium	32	11
Lorazepam	Lorazepam	31	11
Xarelto	Rivaroxaban	31	suppressed
Benazepril Hcl	Benazepril Hcl	30	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	29	suppressed
Meloxicam	Meloxicam	28	12
Triamcinolone Acetonide	Triamcinolone Acetonide	28	17
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Ezetimibe	Ezetimibe	27	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	26	suppressed
Alprazolam	Alprazolam	25	suppressed
Enalapril Maleate	Enalapril Maleate	25	suppressed
Clonidine Hcl	Clonidine Hcl	24	suppressed
Azithromycin	Azithromycin	23	14
Lovastatin	Lovastatin	23	suppressed
Tramadol Hcl	Tramadol Hcl	23	suppressed
Trazodone Hcl	Trazodone Hcl	23	suppressed
Citalopram Hbr	Citalopram Hydrobromide	22	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	22	16
Clopidogrel	Clopidogrel Bisulfate	21	suppressed
Fenofibrate	Fenofibrate,micronized	21	suppressed
Memantine Hcl	Memantine Hcl	21	suppressed
Metformin Hcl Er	Metformin Hcl	21	11
Topiramate	Topiramate	21	suppressed
Fenofibrate	Fenofibrate	20	suppressed
Divalproex Sodium	Divalproex Sodium	19	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	19	13
Farxiga	Dapagliflozin Propanediol	19	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	19	suppressed
Propranolol Hcl	Propranolol Hcl	19	suppressed
Dutasteride	Dutasteride	18	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	18	suppressed
Fluconazole	Fluconazole	18	suppressed
Mupirocin	Mupirocin	18	13
Simvastatin	Simvastatin	18	suppressed
Tresiba Flextouch U-200	Insulin Degludec	18	suppressed
Estradiol	Estradiol	17	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	17	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	17	11
Metronidazole	Metronidazole	16	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	16	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	16	suppressed
Chlorthalidone	Chlorthalidone	15	suppressed
Ondansetron Odt	Ondansetron	15	suppressed
Oxycodone Hcl	Oxycodone Hcl	15	suppressed
Fluticasone Propionate	Fluticasone Propionate	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Celecoxib	Celecoxib	13	suppressed
Morphine Sulfate	Morphine Sulfate	13	suppressed
Morphine Sulfate Er	Morphine Sulfate	13	suppressed
Ramipril	Ramipril	13	suppressed
Atenolol	Atenolol	12	suppressed
Benztropine Mesylate	Benztropine Mesylate	12	suppressed
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	12	suppressed
Carbamazepine Er	Carbamazepine	12	suppressed
Cephalexin	Cephalexin	12	suppressed
Donepezil Hcl	Donepezil Hcl	12	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	12	suppressed
Ranolazine Er	Ranolazine	12	suppressed
Trintellix	Vortioxetine Hydrobromide	12	suppressed
Valsartan	Valsartan	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Bupropion Xl	Bupropion Hcl	11	suppressed
Buspirone Hcl	Buspirone Hcl	11	suppressed
Clomipramine Hcl	Clomipramine Hcl	11	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Doxepin Hcl	Doxepin Hcl	11	suppressed
Glipizide	Glipizide	11	suppressed
Hydralazine Hcl	Hydralazine Hcl	11	suppressed
Januvia	Sitagliptin Phosphate	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error